Transfer factor therapy in patients with subacute sclerosing panencephalitis

Area of Science:

• Neurology
• Immunology
• Virology

Background:

• Subacute sclerosing panencephalitis (S.S.P.E.) is a rare, progressive neurological disorder.
• Current treatments for S.S.P.E. have limited efficacy.
• Transfer factor, an immunomodulatory agent, has been explored for various conditions.

Purpose of the Study:

• To evaluate the efficacy of transfer factor therapy in patients with S.S.P.E.
• To assess the impact of transfer factor on the immunological status of S.S.P.E. patients.

Main Methods:

• Thirteen S.S.P.E. patients received transfer factor treatment.
• Transfer factor was prepared from healthy blood donors.
• Humoral and cellular immune responses were monitored before and after therapy.

Main Results:

• No significant influence on disease course was observed, irrespective of transfer factor dosage.
• Intermittent improvements in three patients were attributed to spontaneous remission.
• No significant changes in immune responses correlated with transfer factor therapy.

Conclusions:

• Transfer factor therapy did not demonstrate significant clinical efficacy in S.S.P.E. patients.
• The treatment did not elicit significant changes in humoral or cellular immunity.
• Further research may be needed to explore alternative immunomodulatory approaches for S.S.P.E.